ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2020

Jan 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2020-01-01

Reporting Person: Waddill William D. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-01	Common Stock	A	7500	$0.00	Acquired	54000	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.